At Nuvisan, we specialise in advancing drug discovery and development for cardiovascular diseases through comprehensive and integrated research services. Our capabilities span from target identification and validation to preclinical development and clinical translation. With state-of-the-art technologies and multidisciplinary expertise, we address critical challenges in cardiovascular drug development.
Our cardiovascular research services offer end-to-end solutions, including:
We are constantly expanding our hiPSC-derived cell portfolio in the cardiology and neurology indication spaces.
learn moreExplore how our scientists support your research projects with our immunology platform.
learn more